Xenetic Biosciences, Inc. operates as a biopharmaceutical firm, primarily concentrating on the development of XCART. This cutting-edge personalized chimeric antigen receptor T…
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Xenetic Biosciences, Inc. →Already a subscriber? Sign in
Xcout Intel tracks Xenetic Biosciences, Inc. continuously — this profile deepens as new filings, funding, people and hiring data arrive.